Clinical Trials Logo

Cross Infection clinical trials

View clinical trials related to Cross Infection.

Filter by:

NCT ID: NCT05090657 Completed - Clinical trials for Nosocomial Infection

Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures

BENEFIT-PDT
Start date: February 4, 2022
Phase: Phase 2
Study type: Interventional

This is a Phase 2 single-center, open-label, single-arm, study of a microbiological endpoint using antimicrobial photodynamic therapy (aPDT) for nasal disinfection in all patients (universal) presenting for surgery at an acute care hospital for a wide range of surgical procedures.

NCT ID: NCT04873557 Completed - Clinical trials for Healthcare Associated Infection

Copper Use as Protection Against Antimicrobial Resistance in the ICU

CUPRIC
Start date: November 2, 2020
Phase: N/A
Study type: Interventional

CUPRIC is an investigator initiated and conducted, prospective, quasi-experimental study to determine whether the combined use of copper-alloyed objects plus copper-enriched textiles reduce the burden of MDRO colonization and HAIs incidence in the critically ill population.

NCT ID: NCT04828148 Completed - Covid19 Clinical Trials

Incidence of Infection and Mortality by COVID-19 in Specialists

Start date: March 1, 2021
Phase:
Study type: Observational

In this current study the researchers aim to identify the total number of infections and deaths due to COVID-19 and distinguish which are the risk factors most related to COVID-19 infections and deaths in medical personnel in Mexico.

NCT ID: NCT04819165 Completed - COVID-19 Clinical Trials

Healthcare-associated Infections in Severe COVID-19 During 2020

COVIACS
Start date: March 1, 2020
Phase:
Study type: Observational

In patients who develop ARDS due to SARS-CoV-2 (CARDS), a longer duration of invasive mechanical ventilation (IMV) and ICU stay has been reported compared to ARDS not associated with SARS-CoV-2. Consequently, the days of stay in ICU increase Identifying the risk factors associated with the development of this complication and developing measures aimed at its prevention could have a favorable impact on the clinical course of seriously ill patients.

NCT ID: NCT04780594 Completed - Covid19 Clinical Trials

Impact of the COVID-19 Pandemic on the Surgical Activity of Bellvitge University Hospital

Start date: February 13, 2020
Phase:
Study type: Observational

COVID-19 has been a challenge for hospitals; there was an obvious need to reconvert many spaces in specific areas to attend this pathology, without forgetting the attention to other pathologies and surgery. The objective of the investigators is to evaluate the impact of this pandemic in the patients who underwent surgery in Bellvitge University Hospital, analyzing 2 periods of time: the months before the COVID-19 peak and the COVID-19 peak months.

NCT ID: NCT04770597 Completed - Clinical trials for Healthcare Associated Infection

Monitors to Improve Indoor Carbon Dioxide (CO2) Concentrations in the Hospital

MICH
Start date: February 21, 2021
Phase: N/A
Study type: Interventional

Ventilation with fresh outdoor air has recently gained considerable attention as a means to reduce the potential risk of indoor aerosol transmission of respiratory pathogens such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing coronavirus disease 2019 (COVID-19). Commercial carbon dioxide (CO2) monitors are increasingly used in schools, long-term care facilities, offices and public buildings to monitor indoor ventilation. However, no formal evidence is available to support the effectiveness of feedback from CO2 monitoring devices. Moreover, modern hospitals have superior indoor air quality control systems. The aim of this prospective pilot randomized controlled trial (RCT) is to evaluate whether CO2 monitoring devices would be useful as a means to further maintain lower indoor CO2 concentrations in hospitals.

NCT ID: NCT04748432 Completed - Lipid Metabolism Clinical Trials

Lipid Kinetics of Patients With Pneumonia

Start date: May 25, 2019
Phase:
Study type: Observational [Patient Registry]

Nonfermenting Gram-Negative Bacilli (NFGNB) are aerobic, non-motile, non-lactose fermenting, oxidase-negative, catalase-positive coccobacilli that pose a serious threat to critically ill patients. Primarily Pseudomonas aeruginosa (PA) and Acinetobacter baumannii (AB), are NFGNB which are potential multi-drug resistant (MDR) pathogens that are related to ventilator-associated pneumonia (VAP). In Nonfermenting Gram-Negative Bacilli (NFGNB) infections, which are potential multi-drug resistant (MDR) pathogens, pathogenesis is determined not only by bacterial virulence factors but more importantly by the interaction between bacteria and the host immune system. Thanks to their direct immunomodulatory properties, lipoproteins and lipids bind and neutralise toxic bacterial substances. During the acute phase response and inflammation, HDL presents significant structural and functional changes. This study was planned to evaluate the relationship between the changes of the serum lipid metabolism and other inflammation markers with the antimicrobial resistance status and the results in NFGNB VAP patients. Also, we aimed to investigate whether there is a difference in the clinical characteristics of the patients depending on the resistance profile of NFGNB.

NCT ID: NCT04679610 Completed - Clinical trials for Nosocomial Infection

In Vitro Activity of Ceftolozane-tazobactam Against Contemporary Nosocomial Gram "-" Pathogens Isolated in Russia

Start date: February 1, 2017
Phase:
Study type: Observational

Infections caused by resistant gram-negative bacteria are becoming increasingly prevalent and now constitute a serious threat to public health worldwide because they are difficult to treat and are associated with high morbidity and mortality rates. Among nosocomial infections, the most major threat represent infections caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative pathogens.

NCT ID: NCT04676581 Completed - Clinical trials for Healthcare Associated Infection

Risk Benefit Ratio of Hirudotherapy: Retrospective Single-center Study of 37 Cases Over a Period of 9 Years

AMLEE
Start date: December 15, 2020
Phase:
Study type: Observational

Venous congestion in transplanted or re-implanted tissues remains a common and chal-lenging complication in plastic and reconstructive surgery. Local application of medicinal leeches is effective to reduce postoperative venous congestion of the flap and to restore normal blood flow. However, leech therapy is associated with a number of risks, including infections. Indeed, leeches maintain a symbiotic relationship with Aeromonas species in order to digest blood in their gut. Aeromonas spp. infections can occur 1 to 30 days post-application of leeches and are associated with a dramatic decrease in flap salvage rates (88 to 30%). For these reasons, prophylactic antibiotics and, external decontamination are widely recommended throughout the course of leech therapy. The aim of this study is to investigate the prevalence of side effects (anemia and infection) from patients treated with leeches in French Hospital.

NCT ID: NCT04603079 Completed - Infection Clinical Trials

Nurse Leadership for Hospital Infection Control

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

The aim is to deliver an intervention to promote nurse leadership and decision-making in the hospital setting, by providing them with training for maintaining minimum service delivery standards for hospital infection control with respect to COVID-19; but also other infectious disease burden management.